Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioNxt Solutions Inc C.BNXT

Alternate Symbol(s):  BNXTF

BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active... see more

CSE:BNXT - Post Discussion

BioNxt Solutions Inc > This is looking GREAT again!
View:
Post by wallpaper2 on Jan 12, 2021 3:20pm

This is looking GREAT again!

The co. said they would be on the market early this year with their rapid test breakthrough for the Gold Standard PCR test kit. European approval is a given as long as there are no safety issues, which there aren't. Factor in their recent successes on the Psychedelic therapeutics and Cannabis treatments for Parkinsons and other neurological disorders and you have a MAJOR breakout in the making. If you're sitting on the sidelines you may want to take a renewed look at things. Jmho
Comment by Adwari on Jan 17, 2021 11:18am
Of course there are no safety issues since is an external diagnostic test.  All that is required for it to demonstrate high sensitivity (ability of a test to correctly identify patients with the disease) and specificity (ability of a test to correctly identify people without the disease) by the test kit.
Comment by wallpaper2 on Jan 17, 2021 8:02pm
It's a done deal then...100% slam dunk! You are looking at this share price for the last time.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities